Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report
High-grade squamous intraepithelial lesion of the vulva is a premalignant condition which may be especially resistant to treatments among immunosuppressed patients. We present our experience with the use of topical cidofovir in a refractory case of extensive vulvar high-grade squamous intraepithelia...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-02-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X20904542 |
id |
doaj-59b827a7d62243fbbfbccadc8953a78d |
---|---|
record_format |
Article |
spelling |
doaj-59b827a7d62243fbbfbccadc8953a78d2020-11-25T03:12:03ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2020-02-01810.1177/2050313X20904542Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case reportDarosa Lim0Annie Belisle1Deana Funaro2Division of Dermatology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC, CanadaDepartment of Pathology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC, CanadaDivision of Dermatology, Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC, CanadaHigh-grade squamous intraepithelial lesion of the vulva is a premalignant condition which may be especially resistant to treatments among immunosuppressed patients. We present our experience with the use of topical cidofovir in a refractory case of extensive vulvar high-grade squamous intraepithelial lesion in a 37-year-old transplant patient. Eighteen cycles of cidofovir over a 2-year period led to a sustained significant improvement, mainly of the mucosal lesions and was well tolerated. To our knowledge, we have not seen this therapy described in transplant patients with extensive high-grade squamous intraepithelial lesion.https://doi.org/10.1177/2050313X20904542 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Darosa Lim Annie Belisle Deana Funaro |
spellingShingle |
Darosa Lim Annie Belisle Deana Funaro Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report SAGE Open Medical Case Reports |
author_facet |
Darosa Lim Annie Belisle Deana Funaro |
author_sort |
Darosa Lim |
title |
Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report |
title_short |
Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report |
title_full |
Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report |
title_fullStr |
Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report |
title_full_unstemmed |
Refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: A case report |
title_sort |
refractory extensive vulvar high-grade squamous intraepithelial lesion in an immunosuppressed transplant patient treated with topical cidofovir: a case report |
publisher |
SAGE Publishing |
series |
SAGE Open Medical Case Reports |
issn |
2050-313X |
publishDate |
2020-02-01 |
description |
High-grade squamous intraepithelial lesion of the vulva is a premalignant condition which may be especially resistant to treatments among immunosuppressed patients. We present our experience with the use of topical cidofovir in a refractory case of extensive vulvar high-grade squamous intraepithelial lesion in a 37-year-old transplant patient. Eighteen cycles of cidofovir over a 2-year period led to a sustained significant improvement, mainly of the mucosal lesions and was well tolerated. To our knowledge, we have not seen this therapy described in transplant patients with extensive high-grade squamous intraepithelial lesion. |
url |
https://doi.org/10.1177/2050313X20904542 |
work_keys_str_mv |
AT darosalim refractoryextensivevulvarhighgradesquamousintraepitheliallesioninanimmunosuppressedtransplantpatienttreatedwithtopicalcidofoviracasereport AT anniebelisle refractoryextensivevulvarhighgradesquamousintraepitheliallesioninanimmunosuppressedtransplantpatienttreatedwithtopicalcidofoviracasereport AT deanafunaro refractoryextensivevulvarhighgradesquamousintraepitheliallesioninanimmunosuppressedtransplantpatienttreatedwithtopicalcidofoviracasereport |
_version_ |
1724651671281205248 |